JP2022551066A5 - - Google Patents
Info
- Publication number
- JP2022551066A5 JP2022551066A5 JP2022520062A JP2022520062A JP2022551066A5 JP 2022551066 A5 JP2022551066 A5 JP 2022551066A5 JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022520062 A JP2022520062 A JP 2022520062A JP 2022551066 A5 JP2022551066 A5 JP 2022551066A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- dihydroxy
- biphenyl
- pentyl
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909363P | 2019-10-02 | 2019-10-02 | |
| US62/909,363 | 2019-10-02 | ||
| US202062966418P | 2020-01-27 | 2020-01-27 | |
| US62/966,418 | 2020-01-27 | ||
| PCT/CA2020/051330 WO2021062559A1 (en) | 2019-10-02 | 2020-10-02 | Cannabinoid derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022551066A JP2022551066A (ja) | 2022-12-07 |
| JP2022551066A5 true JP2022551066A5 (cg-RX-API-DMAC10.html) | 2023-10-11 |
Family
ID=75336687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520062A Pending JP2022551066A (ja) | 2019-10-02 | 2020-10-02 | カンナビノイド誘導体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US12325709B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4037676A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2022551066A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2021062559A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007661A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12084407B2 (en) | 2019-11-26 | 2024-09-10 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
| IL312785B2 (en) | 2020-05-19 | 2026-06-01 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use |
| WO2022105810A1 (zh) * | 2020-11-17 | 2022-05-27 | 中国科学院上海药物研究所 | 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用 |
| US20250019345A1 (en) * | 2021-11-10 | 2025-01-16 | London Pharmaceuticals And Research Corporation | New cannabinoid-gabapentinoid conjugates and uses thereof |
| WO2024231957A1 (en) * | 2023-05-11 | 2024-11-14 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) | 2'-{heterocyclyl (aryl/alkyl) methyl}-cannabidiol compounds and process for preparation thereof |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69829574T2 (de) * | 1997-08-26 | 2005-09-15 | Kumiai Chemical Industry Co., Ltd. | Biarylalkylencarbaminsäure-derivate und fungizide für landwirtschaft und gartenbau |
| US7285687B2 (en) * | 2002-04-25 | 2007-10-23 | Virginia Commonwealth University | Cannabinoids |
| MX2007001943A (es) | 2004-08-17 | 2007-05-09 | Galderma Res & Dev | Nuevos compuestos biaromaticos activadores de los receptores del tipo receptor activado del proliferador de peroxisoma (ppar) y su uso en composiciones cosmeticas o farmaceuticas. |
| US8633175B2 (en) | 2006-08-09 | 2014-01-21 | Glaxosmithkline Llc | Compounds as antagonists or inverse agonists at opioid receptors |
| WO2008096769A1 (ja) | 2007-02-08 | 2008-08-14 | Daiichi Sankyo Company, Limited | 置換されたセルコスポラミド誘導体を含有する医薬 |
| AU2009243756B2 (en) | 2008-05-05 | 2013-06-27 | Sanofi-Aventis | Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals |
| JP5766617B2 (ja) | 2009-02-20 | 2015-08-19 | ユニバーシティ・オブ・カンザス | 修飾された糖部分を有するノボビオシン類似体 |
| US9254272B2 (en) * | 2011-11-30 | 2016-02-09 | Sutter West Bay Hospitals | Resorcinol derivatives |
| US9517989B2 (en) * | 2012-10-17 | 2016-12-13 | Northeastern University | 2-cycloalkyl resorcinol cannabinergic ligands |
| EP2762134A1 (en) * | 2013-02-04 | 2014-08-06 | Bioversys AG | Composition for treatment of pathogens that are resistant to tetracyclines |
| CN105555766A (zh) | 2013-07-18 | 2016-05-04 | 诺华股份有限公司 | 作为补体因子d抑制剂的氨基甲基-联芳基衍生物及其应用 |
| ES2547354T3 (es) | 2013-09-03 | 2015-10-05 | Symrise Ag | Mezclas de compuestos cannabinoides, su preparación y uso |
| EP3226847A2 (en) * | 2014-12-04 | 2017-10-11 | Servicio Andaluz De Salud | Use of cannabinoids as ceramide-generating anticancer agents in tumors of the hematopoietic and lymphoid tissues |
| US9717683B1 (en) | 2016-06-29 | 2017-08-01 | Ep Pharma, Llc | Low-temperature inhalation administration of cannabinoid entities |
| US11466283B2 (en) | 2016-08-18 | 2022-10-11 | Canopy Growth Corporation | Plants and methods for increasing and decreasing synthesis of cannabinoids |
| US10640482B2 (en) * | 2017-07-21 | 2020-05-05 | University Of South Florida | Synthesis of cannabinoids |
| WO2019234728A1 (en) | 2018-06-04 | 2019-12-12 | Al&Am Pharmachem Ltd. | Cannabinolic acid derivatives and uses thereof |
| TW202024023A (zh) * | 2018-09-03 | 2020-07-01 | 瑞士商赫孚孟拉羅股份公司 | 治療性化合物及其使用方法 |
| CA3138732A1 (en) | 2018-11-30 | 2020-06-04 | Canopy Growth Corporation | Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use |
| WO2020107119A1 (en) | 2018-11-30 | 2020-06-04 | Canopy Growth Corporation | Compositions comprising a cannabinoid or a cannabis-derived compound, methods of making and use |
| WO2020198874A1 (en) * | 2019-04-04 | 2020-10-08 | Scf Pharma Inc. | Cannabidiolic acid monoglycerides, derivatives, and uses thereof |
| EP3994114A4 (en) | 2019-07-04 | 2023-08-16 | Canopy Growth Corporation | CANNABINOID DERIVATIVES |
| US20220242844A1 (en) | 2019-07-04 | 2022-08-04 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007663A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| EP3997098A4 (en) | 2019-07-12 | 2023-10-11 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007660A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007659A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021007661A1 (en) | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| WO2021062557A1 (en) | 2019-10-02 | 2021-04-08 | Canopy Growth Corporation | Cannabinoid derivatives |
| JP2023503330A (ja) | 2019-11-26 | 2023-01-27 | キャノピー グロウス コーポレイション | カンナビノイド誘導体 |
| US12084407B2 (en) | 2019-11-26 | 2024-09-10 | Canopy Growth Corporation | Cannabigerol derivatives and use thereof as cannabinoid receptor modulators |
| US20230122510A1 (en) | 2019-11-26 | 2023-04-20 | Canopy Growth Corporation | Cannabinoid derivatives |
| US20230059582A1 (en) | 2019-12-09 | 2023-02-23 | Canopy Growth Corporation | Cannabinoid derivatives |
| US12617765B2 (en) | 2019-12-09 | 2026-05-05 | Canopy Growth Corporation | Cannabinoid derivatives |
-
2020
- 2020-10-02 JP JP2022520062A patent/JP2022551066A/ja active Pending
- 2020-10-02 WO PCT/CA2020/051330 patent/WO2021062559A1/en not_active Ceased
- 2020-10-02 US US17/765,856 patent/US12325709B2/en active Active
- 2020-10-02 EP EP20870467.6A patent/EP4037676A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022551067A5 (cg-RX-API-DMAC10.html) | ||
| JP2022540434A5 (cg-RX-API-DMAC10.html) | ||
| JP2023503330A5 (cg-RX-API-DMAC10.html) | ||
| JP2022539400A5 (cg-RX-API-DMAC10.html) | ||
| JP2023503601A5 (cg-RX-API-DMAC10.html) | ||
| JP7642707B2 (ja) | カルバモイルフェニルアラニノール類縁体およびその使用 | |
| ES2313391T3 (es) | 1,1a,5,5a-tetrahidro-3-tia-ciclopropa(a)pentalenos: derivados de tiofeno triciclico como agonistas del receptor s1p1/edg1. | |
| JP2022540432A5 (cg-RX-API-DMAC10.html) | ||
| SK284068B6 (sk) | Ester odvodený od substituovanej fenylcyklohexylovej zlúčeniny, spôsob jeho prípravy a použitie | |
| US7741355B2 (en) | Small-molecule modulators of TRP-p8 activity | |
| RU2012120387A (ru) | Замещенные производные 4-аминоциклогексана | |
| JP2013507374A (ja) | Gタンパク質共役受容体88の修飾因子 | |
| RU2008144415A (ru) | Композиции, полезные в качестве ингибиторов потенциалзависимых натриевых каналов | |
| RU2012129737A (ru) | Замещенные бензамидные производные | |
| JP2022540586A5 (cg-RX-API-DMAC10.html) | ||
| RU2015149528A (ru) | 2-фенилимидазо[1,2-а]пиримидины в качестве визуализирующих средств | |
| JP2008013556A (ja) | 新規ナフタレン化合物、その製造法、およびそれを含有する薬学的組成物 | |
| EP2888239B1 (en) | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes | |
| JP2013538198A5 (cg-RX-API-DMAC10.html) | ||
| US6566554B1 (en) | Aminobenzophenones as inhibitors of IL-1β and TNF-α | |
| JP2021515004A5 (cg-RX-API-DMAC10.html) | ||
| CA2716961A1 (fr) | Composes derives d'azetidines, leur preparation et leur application en therapeutique | |
| FR2843964A1 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
| CN101115728B (zh) | 三唑取代的氨基二苯甲酮化合物 | |
| AU5806900A (en) | Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |